LeMaitre Vascular (LMAT) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed LeMaitre Vascular (LMAT) over the past year, gaining 16.5% versus a loss of 9.5%. Over five years, LMAT leads with a +48.6% price change compared with -17.9% for UTMD. LeMaitre Vascular is the larger company by market cap ($1.82 billion vs $234.5 million), about 7.8 times the size.
On valuation, Utah Medical Products trades at a lower trailing P/E (22.5x vs 27.9x for LeMaitre Vascular). Utah Medical Products offers the higher dividend yield (1.67% vs 1.13%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMAT | UTMD |
|---|---|---|
| Share price | $79.64 | $73.88 |
| Market cap | $1.82B | $234.47M |
| 1-day change | +0.42% | +0.58% |
| YTD return | -1.80% | +32.01% |
| 1-year return | -9.54% | +16.47% |
| 5-year return | +48.64% | -17.93% |
| P/E ratio (TTM) | 27.94 | 22.52 |
| Forward P/E | 25.05 | — |
| EPS (TTM) | $2.85 | $3.28 |
| Dividend yield | 1.13% | 1.67% |
| Annual dividend | $0.90 | $1.24 |
| 52-week high | $118.01 | $76.89 |
| 52-week low | $78.22 | $53.66 |
| Distance from 52-week high | -32.51% | -3.92% |
| Analyst consensus | buy | — |
| Avg. price target upside | +34.35% | — |
| Average volume | 330.14K | 34.56K |
| Shares outstanding | 22.87M | 3.17M |
| Employees | 646 | 140 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LeMaitre Vascular is about 7.8 times larger than Utah Medical Products by market value ($1.82B vs $234.47M).
- UTMD has outperformed LMAT by 26.0 percentage points over the past year.
About LeMaitre Vascular
LMAT stock →LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Healthcare · Medical Instruments & Supplies · 646 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Healthcare · Medical Instruments & Supplies · 140 employees
LMAT vs UTMD FAQ
Which is bigger, LeMaitre Vascular or Utah Medical Products?
LeMaitre Vascular (LMAT) is larger, with a market capitalization of $1.82B compared with $234.47M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, LMAT or UTMD?
UTMD returned +16.47% over the past 12 months, compared with -9.54% for LMAT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, LMAT or UTMD?
UTMD has the lower trailing P/E at 22.5, versus 27.9 for LMAT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, LeMaitre Vascular or Utah Medical Products?
Utah Medical Products has the higher yield at 1.67%, compared with 1.13% for LeMaitre Vascular.
Are LeMaitre Vascular and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.